The invention relates to the use of biotin for treating multiple sclerosis, in particular of the progressive forms and of the neurological sequelae, wherein the treatment with biotin has a duration of at least 3 months.La présente invention concerne l'utilisation de biotine pour le traitement de la sclérose en plaques, en particulier des formes progressives et des séquelles neurologiques.